NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation.
BACKGROUND:Chronic obstructive pulmonary disease (COPD) is an inflammatory disease characterized by a progressive and irreversible deterioration of lung function. Exacerbations of COPD have prolonged negative effects on pulmonary function and a major impact on health status and outcomes. NLRP3 infla...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0214622 |
| _version_ | 1819144249520685056 |
|---|---|
| author | Noy Nachmias Sheila Langier Rafael Y Brzezinski Matan Siterman Moshe Stark Sara Etkin Avital Avriel Yehuda Schwarz Shani Shenhar-Tsarfaty Amir Bar-Shai |
| author_facet | Noy Nachmias Sheila Langier Rafael Y Brzezinski Matan Siterman Moshe Stark Sara Etkin Avital Avriel Yehuda Schwarz Shani Shenhar-Tsarfaty Amir Bar-Shai |
| author_sort | Noy Nachmias |
| collection | DOAJ |
| description | BACKGROUND:Chronic obstructive pulmonary disease (COPD) is an inflammatory disease characterized by a progressive and irreversible deterioration of lung function. Exacerbations of COPD have prolonged negative effects on pulmonary function and a major impact on health status and outcomes. NLRP3 inflammasome is a cardinal component of the inflammatory response, with marked evidence in stable and exacerbations of COPD. The aim of our study was to evaluate the NLRP3 inflammasome activity during COPD exacerbation by using an in vitro model. METHODS:A549 cells were stimulated with different concentrations (10%, 4%, 2%) of cigarette smoke extract (CSE) with or without LPS (0.1μg/ml) for 24 hours. Cell viability was assessed by using XTT test. Levels of inflammatory cytokines (IL-8, MCP-1, and IL-1β) were measured by ELISA and the activity level of NLRP-3 was evaluated by flow cytometry. RESULTS:Cells exposed to CSE present an increase in inflammatory cytokines (IL-8 and MCP-1) production in a dose-dependent manner. Incubation with LPS to these cells results in higher levels of IL-8 and MCP-1 compared to stimulation of CSE alone. NLRP3 inflammasome activity and IL-1β levels were significantly increased in cells exposed to both CSE and LPS compared to CSE alone. CONCLUSIONS:NLRP3 inflammasome is upregulated in an in-vitro model of COPD and COPD exacerbation. Our findings provide novel biomarkers for COPD exacerbation and may present new targets for future research. |
| first_indexed | 2024-12-22T12:39:08Z |
| format | Article |
| id | doaj.art-19ef2a96272941539167823e914cbf88 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T12:39:08Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-19ef2a96272941539167823e914cbf882022-12-21T18:25:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01145e021462210.1371/journal.pone.0214622NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation.Noy NachmiasSheila LangierRafael Y BrzezinskiMatan SitermanMoshe StarkSara EtkinAvital AvrielYehuda SchwarzShani Shenhar-TsarfatyAmir Bar-ShaiBACKGROUND:Chronic obstructive pulmonary disease (COPD) is an inflammatory disease characterized by a progressive and irreversible deterioration of lung function. Exacerbations of COPD have prolonged negative effects on pulmonary function and a major impact on health status and outcomes. NLRP3 inflammasome is a cardinal component of the inflammatory response, with marked evidence in stable and exacerbations of COPD. The aim of our study was to evaluate the NLRP3 inflammasome activity during COPD exacerbation by using an in vitro model. METHODS:A549 cells were stimulated with different concentrations (10%, 4%, 2%) of cigarette smoke extract (CSE) with or without LPS (0.1μg/ml) for 24 hours. Cell viability was assessed by using XTT test. Levels of inflammatory cytokines (IL-8, MCP-1, and IL-1β) were measured by ELISA and the activity level of NLRP-3 was evaluated by flow cytometry. RESULTS:Cells exposed to CSE present an increase in inflammatory cytokines (IL-8 and MCP-1) production in a dose-dependent manner. Incubation with LPS to these cells results in higher levels of IL-8 and MCP-1 compared to stimulation of CSE alone. NLRP3 inflammasome activity and IL-1β levels were significantly increased in cells exposed to both CSE and LPS compared to CSE alone. CONCLUSIONS:NLRP3 inflammasome is upregulated in an in-vitro model of COPD and COPD exacerbation. Our findings provide novel biomarkers for COPD exacerbation and may present new targets for future research.https://doi.org/10.1371/journal.pone.0214622 |
| spellingShingle | Noy Nachmias Sheila Langier Rafael Y Brzezinski Matan Siterman Moshe Stark Sara Etkin Avital Avriel Yehuda Schwarz Shani Shenhar-Tsarfaty Amir Bar-Shai NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. PLoS ONE |
| title | NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. |
| title_full | NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. |
| title_fullStr | NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. |
| title_full_unstemmed | NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. |
| title_short | NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. |
| title_sort | nlrp3 inflammasome activity is upregulated in an in vitro model of copd exacerbation |
| url | https://doi.org/10.1371/journal.pone.0214622 |
| work_keys_str_mv | AT noynachmias nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT sheilalangier nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT rafaelybrzezinski nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT matansiterman nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT moshestark nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT saraetkin nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT avitalavriel nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT yehudaschwarz nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT shanishenhartsarfaty nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation AT amirbarshai nlrp3inflammasomeactivityisupregulatedinaninvitromodelofcopdexacerbation |